Anti-inflammatory therapeutics are primarily used to reduce inflammation. These drugs are types of analgesics that are used for reducing pain.
The global anti-inflammatory therapeutics market will grow steadily at a CAGR of over 6% by 2021. This market research analysis identifies the increase in the prevalence of immune-mediated inflammatory disease (IMID) as one of the primary growth factors for this market. IMID includes a group of disabling conditions that share a common inflammatory pathway including conditions like ankylosing spondylitis (AS), ulcerative colitis, multiple sclerosis (MS), rheumatoid arthritis (RA), and inflammatory bowel disease (IBD) and these conditions can affect an organ, resulting in significant morbidity and reduced quality of life.
The global Anti-inflammatory Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-inflammatory Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-inflammatory Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-inflammatory Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-inflammatory Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie
Amgen
Johnson & Johnson
Pfizer
Boehringer Ingelheim
Eli Lilly
Novartis
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Anti-Inflammatory Biologicals
NSAIDs
Corticosteroids
Segment by Application
Hospitals
Clinics
The global anti-inflammatory therapeutics market will grow steadily at a CAGR of over 6% by 2021. This market research analysis identifies the increase in the prevalence of immune-mediated inflammatory disease (IMID) as one of the primary growth factors for this market. IMID includes a group of disabling conditions that share a common inflammatory pathway including conditions like ankylosing spondylitis (AS), ulcerative colitis, multiple sclerosis (MS), rheumatoid arthritis (RA), and inflammatory bowel disease (IBD) and these conditions can affect an organ, resulting in significant morbidity and reduced quality of life.
The global Anti-inflammatory Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-inflammatory Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-inflammatory Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-inflammatory Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-inflammatory Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie
Amgen
Johnson & Johnson
Pfizer
Boehringer Ingelheim
Eli Lilly
Novartis
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Anti-Inflammatory Biologicals
NSAIDs
Corticosteroids
Segment by Application
Hospitals
Clinics
Table of Contents
Executive Summary
1 Industry Overview of Anti-inflammatory Therapeutics
1.1 Definition of Anti-inflammatory Therapeutics
1.2 Anti-inflammatory Therapeutics Segment by Type
1.2.1 Global Anti-inflammatory Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Anti-Inflammatory Biologicals
1.2.3 NSAIDs
1.2.4 Corticosteroids
1.3 Anti-inflammatory Therapeutics Segment by Applications
1.3.1 Global Anti-inflammatory Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Anti-inflammatory Therapeutics Overall Market
1.4.1 Global Anti-inflammatory Therapeutics Revenue (2014-2025)
1.4.2 Global Anti-inflammatory Therapeutics Production (2014-2025)
1.4.3 North America Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.5 China Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.8 India Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Anti-inflammatory Therapeutics
2.3 Manufacturing Process Analysis of Anti-inflammatory Therapeutics
2.4 Industry Chain Structure of Anti-inflammatory Therapeutics
3 Development and Manufacturing Plants Analysis of Anti-inflammatory Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Anti-inflammatory Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Anti-inflammatory Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Anti-inflammatory Therapeutics Production and Capacity Analysis
4.2 Anti-inflammatory Therapeutics Revenue Analysis
4.3 Anti-inflammatory Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Anti-inflammatory Therapeutics Regional Market Analysis
5.1 Anti-inflammatory Therapeutics Production by Regions
5.1.1 Global Anti-inflammatory Therapeutics Production by Regions
5.1.2 Global Anti-inflammatory Therapeutics Revenue by Regions
5.2 Anti-inflammatory Therapeutics Consumption by Regions
5.3 North America Anti-inflammatory Therapeutics Market Analysis
5.3.1 North America Anti-inflammatory Therapeutics Production
5.3.2 North America Anti-inflammatory Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Anti-inflammatory Therapeutics Import and Export
5.4 Europe Anti-inflammatory Therapeutics Market Analysis
5.4.1 Europe Anti-inflammatory Therapeutics Production
5.4.2 Europe Anti-inflammatory Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Anti-inflammatory Therapeutics Import and Export
5.5 China Anti-inflammatory Therapeutics Market Analysis
5.5.1 China Anti-inflammatory Therapeutics Production
5.5.2 China Anti-inflammatory Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Anti-inflammatory Therapeutics Import and Export
5.6 Japan Anti-inflammatory Therapeutics Market Analysis
5.6.1 Japan Anti-inflammatory Therapeutics Production
5.6.2 Japan Anti-inflammatory Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Anti-inflammatory Therapeutics Import and Export
5.7 Southeast Asia Anti-inflammatory Therapeutics Market Analysis
5.7.1 Southeast Asia Anti-inflammatory Therapeutics Production
5.7.2 Southeast Asia Anti-inflammatory Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Anti-inflammatory Therapeutics Import and Export
5.8 India Anti-inflammatory Therapeutics Market Analysis
5.8.1 India Anti-inflammatory Therapeutics Production
5.8.2 India Anti-inflammatory Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Anti-inflammatory Therapeutics Import and Export
6 Anti-inflammatory Therapeutics Segment Market Analysis (by Type)
6.1 Global Anti-inflammatory Therapeutics Production by Type
6.2 Global Anti-inflammatory Therapeutics Revenue by Type
6.3 Anti-inflammatory Therapeutics Price by Type
7 Anti-inflammatory Therapeutics Segment Market Analysis (by Application)
7.1 Global Anti-inflammatory Therapeutics Consumption by Application
7.2 Global Anti-inflammatory Therapeutics Consumption Market Share by Application (2014-2019)
8 Anti-inflammatory Therapeutics Major Manufacturers Analysis
8.1 AbbVie
8.1.1 AbbVie Anti-inflammatory Therapeutics Production Sites and Area Served
8.1.2 AbbVie Product Introduction, Application and Specification
8.1.3 AbbVie Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen
8.2.1 Amgen Anti-inflammatory Therapeutics Production Sites and Area Served
8.2.2 Amgen Product Introduction, Application and Specification
8.2.3 Amgen Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Anti-inflammatory Therapeutics Production Sites and Area Served
8.3.2 Johnson & Johnson Product Introduction, Application and Specification
8.3.3 Johnson & Johnson Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer Anti-inflammatory Therapeutics Production Sites and Area Served
8.4.2 Pfizer Product Introduction, Application and Specification
8.4.3 Pfizer Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Boehringer Ingelheim
8.5.1 Boehringer Ingelheim Anti-inflammatory Therapeutics Production Sites and Area Served
8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.5.3 Boehringer Ingelheim Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eli Lilly
8.6.1 Eli Lilly Anti-inflammatory Therapeutics Production Sites and Area Served
8.6.2 Eli Lilly Product Introduction, Application and Specification
8.6.3 Eli Lilly Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novartis
8.7.1 Novartis Anti-inflammatory Therapeutics Production Sites and Area Served
8.7.2 Novartis Product Introduction, Application and Specification
8.7.3 Novartis Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Anti-inflammatory Therapeutics Market
9.1 Global Anti-inflammatory Therapeutics Market Trend Analysis
9.1.1 Global Anti-inflammatory Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Anti-inflammatory Therapeutics Regional Market Trend
9.2.1 North America Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.2 Europe Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.3 China Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.4 Japan Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.6 India Anti-inflammatory Therapeutics Forecast 2019-2025
9.3 Anti-inflammatory Therapeutics Market Trend (Product Type)
9.4 Anti-inflammatory Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Anti-inflammatory Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Anti-inflammatory Therapeutics
1.1 Definition of Anti-inflammatory Therapeutics
1.2 Anti-inflammatory Therapeutics Segment by Type
1.2.1 Global Anti-inflammatory Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Anti-Inflammatory Biologicals
1.2.3 NSAIDs
1.2.4 Corticosteroids
1.3 Anti-inflammatory Therapeutics Segment by Applications
1.3.1 Global Anti-inflammatory Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Anti-inflammatory Therapeutics Overall Market
1.4.1 Global Anti-inflammatory Therapeutics Revenue (2014-2025)
1.4.2 Global Anti-inflammatory Therapeutics Production (2014-2025)
1.4.3 North America Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.5 China Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
1.4.8 India Anti-inflammatory Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Anti-inflammatory Therapeutics
2.3 Manufacturing Process Analysis of Anti-inflammatory Therapeutics
2.4 Industry Chain Structure of Anti-inflammatory Therapeutics
3 Development and Manufacturing Plants Analysis of Anti-inflammatory Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Anti-inflammatory Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Anti-inflammatory Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Anti-inflammatory Therapeutics Production and Capacity Analysis
4.2 Anti-inflammatory Therapeutics Revenue Analysis
4.3 Anti-inflammatory Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Anti-inflammatory Therapeutics Regional Market Analysis
5.1 Anti-inflammatory Therapeutics Production by Regions
5.1.1 Global Anti-inflammatory Therapeutics Production by Regions
5.1.2 Global Anti-inflammatory Therapeutics Revenue by Regions
5.2 Anti-inflammatory Therapeutics Consumption by Regions
5.3 North America Anti-inflammatory Therapeutics Market Analysis
5.3.1 North America Anti-inflammatory Therapeutics Production
5.3.2 North America Anti-inflammatory Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Anti-inflammatory Therapeutics Import and Export
5.4 Europe Anti-inflammatory Therapeutics Market Analysis
5.4.1 Europe Anti-inflammatory Therapeutics Production
5.4.2 Europe Anti-inflammatory Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Anti-inflammatory Therapeutics Import and Export
5.5 China Anti-inflammatory Therapeutics Market Analysis
5.5.1 China Anti-inflammatory Therapeutics Production
5.5.2 China Anti-inflammatory Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Anti-inflammatory Therapeutics Import and Export
5.6 Japan Anti-inflammatory Therapeutics Market Analysis
5.6.1 Japan Anti-inflammatory Therapeutics Production
5.6.2 Japan Anti-inflammatory Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Anti-inflammatory Therapeutics Import and Export
5.7 Southeast Asia Anti-inflammatory Therapeutics Market Analysis
5.7.1 Southeast Asia Anti-inflammatory Therapeutics Production
5.7.2 Southeast Asia Anti-inflammatory Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Anti-inflammatory Therapeutics Import and Export
5.8 India Anti-inflammatory Therapeutics Market Analysis
5.8.1 India Anti-inflammatory Therapeutics Production
5.8.2 India Anti-inflammatory Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Anti-inflammatory Therapeutics Import and Export
6 Anti-inflammatory Therapeutics Segment Market Analysis (by Type)
6.1 Global Anti-inflammatory Therapeutics Production by Type
6.2 Global Anti-inflammatory Therapeutics Revenue by Type
6.3 Anti-inflammatory Therapeutics Price by Type
7 Anti-inflammatory Therapeutics Segment Market Analysis (by Application)
7.1 Global Anti-inflammatory Therapeutics Consumption by Application
7.2 Global Anti-inflammatory Therapeutics Consumption Market Share by Application (2014-2019)
8 Anti-inflammatory Therapeutics Major Manufacturers Analysis
8.1 AbbVie
8.1.1 AbbVie Anti-inflammatory Therapeutics Production Sites and Area Served
8.1.2 AbbVie Product Introduction, Application and Specification
8.1.3 AbbVie Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen
8.2.1 Amgen Anti-inflammatory Therapeutics Production Sites and Area Served
8.2.2 Amgen Product Introduction, Application and Specification
8.2.3 Amgen Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Anti-inflammatory Therapeutics Production Sites and Area Served
8.3.2 Johnson & Johnson Product Introduction, Application and Specification
8.3.3 Johnson & Johnson Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer Anti-inflammatory Therapeutics Production Sites and Area Served
8.4.2 Pfizer Product Introduction, Application and Specification
8.4.3 Pfizer Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Boehringer Ingelheim
8.5.1 Boehringer Ingelheim Anti-inflammatory Therapeutics Production Sites and Area Served
8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.5.3 Boehringer Ingelheim Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eli Lilly
8.6.1 Eli Lilly Anti-inflammatory Therapeutics Production Sites and Area Served
8.6.2 Eli Lilly Product Introduction, Application and Specification
8.6.3 Eli Lilly Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novartis
8.7.1 Novartis Anti-inflammatory Therapeutics Production Sites and Area Served
8.7.2 Novartis Product Introduction, Application and Specification
8.7.3 Novartis Anti-inflammatory Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Anti-inflammatory Therapeutics Market
9.1 Global Anti-inflammatory Therapeutics Market Trend Analysis
9.1.1 Global Anti-inflammatory Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Anti-inflammatory Therapeutics Regional Market Trend
9.2.1 North America Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.2 Europe Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.3 China Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.4 Japan Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Anti-inflammatory Therapeutics Forecast 2019-2025
9.2.6 India Anti-inflammatory Therapeutics Forecast 2019-2025
9.3 Anti-inflammatory Therapeutics Market Trend (Product Type)
9.4 Anti-inflammatory Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Anti-inflammatory Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
